Brigatinib
ATC L01ED04 · 11 markets · 46 records
AU 12 records · 4 strengths
- 90 mgtabletAlunbrigALUNBRIG brigatinib 180 mg film-coated tablet blister pack、ALUNBRIG brigatinib 30 mg film-coated tablet bottle、ALUNBRIG brigatinib 90 mg and 180 mg film-coated tablets blister pack
- 180 mgtabletAlunbrigALUNBRIG brigatinib 180 mg film-coated tablet blister pack、ALUNBRIG brigatinib 30 mg film-coated tablet bottle、ALUNBRIG brigatinib 90 mg and 180 mg film-coated tablets blister pack
- 30 mgtabletAlunbrigALUNBRIG brigatinib 180 mg film-coated tablet blister pack、ALUNBRIG brigatinib 30 mg film-coated tablet bottle
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 4 records · 3 strengths
CA 4 records · 3 strengths
SG 4 records · 3 strengths
CN 4 records · 3 strengths
ES 4 records · 3 strengths
FR 4 records · 3 strengths
- 90 mgtabletALUNBRIG 180 mg, comprimé pelliculé
- 180 mgtabletALUNBRIG 180 mg, comprimé pelliculé
- 30 mgtabletALUNBRIG 180 mg, comprimé pelliculé
US 3 records · 3 strengths
TW 3 records · 3 strengths
HK 3 records · 1 strengths
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 90 mg tablet | Alunbrig | Alunbrig Alunbrig 90mg/180mg tablets treatment initiation pack | Alunbrig | Alunbrig ALUNBRIG brigatinib 180 mg film-coated tablet blister pack ALUNBRIG brigatinib 30 mg film-coated tablet bottle+1ALUNBRIG brigatinib 90 mg and 180 mg film-coated tablets blister pack | Alunbrig ALUNBRIG INITIATION PACK | 安伯瑞布格替尼 | Alunbrig | Alunbrig 癌能畢 膜衣錠90毫克 | ALUNBRIG 180 mg, comprimé pelliculé | ||
| 180 mg tablet | Alunbrig | Alunbrig | Alunbrig | Alunbrig ALUNBRIG brigatinib 180 mg film-coated tablet blister pack ALUNBRIG brigatinib 30 mg film-coated tablet bottle+1ALUNBRIG brigatinib 90 mg and 180 mg film-coated tablets blister pack | Alunbrig ALUNBRIG INITIATION PACK | 安伯瑞布格替尼 | Alunbrig | Alunbrig 癌能畢 膜衣錠180毫克 | ALUNBRIG 180 mg, comprimé pelliculé | ||
| 30 mg tablet | Alunbrig | Alunbrig | Alunbrig | Alunbrig ALUNBRIG brigatinib 180 mg film-coated tablet blister pack ALUNBRIG brigatinib 30 mg film-coated tablet bottle | Alunbrig | 安伯瑞布格替尼 | Alunbrig | Alunbrig 癌能畢 膜衣錠30毫克 | ALUNBRIG 180 mg, comprimé pelliculé | ||
unknown | Alunbrig | Alunbrig | Alunbrig |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.